A detailed history of Cvi Holdings, LLC transactions in Renalytix PLC stock. As of the latest transaction made, Cvi Holdings, LLC holds 38,346 shares of RNLX stock, worth $5,751. This represents 0.07% of its overall portfolio holdings.

Number of Shares
38,346
Holding current value
$5,751
% of portfolio
0.07%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$0.23 - $0.93 $8,819 - $35,661
38,346 New
38,346 $8,000
Q4 2023

Feb 14, 2024

BUY
$0.33 - $1.61 $301,708 - $1.47 Million
914,269 Added 397.45%
1,144,305 $446,000
Q3 2023

Nov 14, 2023

BUY
$1.51 - $4.01 $347,354 - $922,444
230,036 New
230,036 $368,000

Others Institutions Holding RNLX

About Renalytix plc


  • Ticker RNLX
  • Exchange OTC
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 37,445,900
  • Market Cap $5.62M
  • Description
  • Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...
More about RNLX
Track This Portfolio

Track Cvi Holdings, LLC Portfolio

Follow Cvi Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cvi Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cvi Holdings, LLC with notifications on news.